Ware Olivia C
SEC insider (Form 3/4/5 filer). CIK 0001663771. Director at Contineum Therapeutics, Inc. (CTNM) and 2 other issuers. 9 reported Form 4/5 transactions since Sep 2024; latest on Jun 26, 2026. Located in SAN DIEGO, CA.
Companies Ware Olivia C has filed insider reports for
- Contineum Therapeutics, Inc. (CTNM): Director
- Arcellx, Inc. (ACLX): Director
- Revance Therapeutics, Inc. (RVNC): Director
Ware Olivia C
CIK: 0001663771
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jun 26, 2026CTNM
Contineum Therapeutics, Inc.
AwardDirectStock Option (right to buy)
19K shares- - Apr 28, 2026ACLX
Arcellx, Inc.
DispositionDirectStock Option (right to buy)
8K shares- - Apr 28, 2026ACLX
Arcellx, Inc.
DispositionDirectStock Option (right to buy)
9.2K shares- - Apr 28, 2026ACLX
Arcellx, Inc.
DispositionDirectStock Option (right to buy)
36.8K shares- - Apr 28, 2026ACLX
Arcellx, Inc.
DispositionDirectStock Option (right to buy)
11.5K shares- - Jun 26, 2025CTNM
Contineum Therapeutics, Inc.
AwardDirectStock Option (right to buy)
14.8K shares- - May 29, 2025ACLX
Arcellx, Inc.
AwardDirectStock Option (right to buy)
9.2K shares- - Feb 6, 2025RVNC
Revance Therapeutics, Inc.
DispositionDirect15K shares- - Feb 4, 2025RVNC
Revance Therapeutics, Inc.
Tender OfferDirect16.7K shares at avg. $3.65$61K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 26, 2026 |  CTNM Contineum Therapeutics, Inc. | Award Stock Option (right to buy) | 19,000 | - | - | Direct |
| Apr 28, 2026 |  ACLX Arcellx, Inc. | Disposition Stock Option (right to buy) | 8,011 | - | - | Direct |
| Apr 28, 2026 | ACLX Arcellx, Inc. | Disposition Stock Option (right to buy) | 9,174 | - | - | Direct |
| Apr 28, 2026 | ACLX Arcellx, Inc. | Disposition Stock Option (right to buy) | 36,806 | - | - | Direct |
| Apr 28, 2026 | ACLX Arcellx, Inc. | Disposition Stock Option (right to buy) | 11,459 | - | - | Direct |
| Jun 26, 2025 | CTNM Contineum Therapeutics, Inc. | Award Stock Option (right to buy) | 14,750 | - | - | Direct |
| May 29, 2025 | ACLX Arcellx, Inc. | Award Stock Option (right to buy) | 9,174 | - | - | Direct |
| Feb 6, 2025 |  RVNC Revance Therapeutics, Inc. | Disposition | 15,000 | - | - | Direct |
| Feb 4, 2025 | RVNC Revance Therapeutics, Inc. | Tender Offer | 16,675 | $3.65 | $60,864 | Direct |
1-9 of 9 transactions